Macular Degeneration, Dry, AREA[OverallStatus], Open or Pending: 55 Clinical Trials, Page 1 of 6

GOLDEN STUDY: A Study to Assess Safety and Efficacy of Multiple Doses of IONIS-FB-LRx in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Condition(s):Macular Degeneration; Geographic AtrophyLast Updated:December 7, 2020Recruiting

Intravitreal AAVCAGsCD59 for Advanced Dry Age-related Macular Degeneration (AMD) With Geographic Atrophy (GA)

Condition(s):Dry Age-related Macular Degeneration; Geographic Atrophy; Gene Therapy; Intravitreal InjectionLast Updated:June 23, 2020Not yet recruiting

A Study Investigating the Efficacy and Safety of Intravitreal Injections of ANX007 in Patients With Geographic Atrophy

Condition(s):Geographic AtrophyLast Updated:December 7, 2020Not yet recruiting

A Study of NGM621 in Participants With Geographic Atrophy

Condition(s):Geographic AtrophyLast Updated:December 2, 2020Recruiting

Metformin for the Minimization of Geographic Atrophy Progression in Patients With AMD

Condition(s):Age-Related Macular Degeneration; Macular Degeneration, Age-Related; Dry Macular Degeneration; Geographic AtrophyLast Updated:March 30, 2020Recruiting

A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Immunogenicity of Intravitreal Injections of RO7303359 in Participants With Geographic Atrophy

Condition(s):Geographic AtrophyLast Updated:January 12, 2021Recruiting

A Study Assessing the Long-Term Safety and Tolerability of RG6147 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration

Condition(s):Macular Degeneration, Age-Related; Geographic AtrophyLast Updated:January 5, 2021Recruiting

A Study Assessing the Safety, Tolerability, and Efficacy of RG6147 in Participants With Geographic Atrophy Secondary to Age-Related Macular Degeneration (AMD)

Condition(s):Macular Degeneration, Age-Related; Geographic AtrophyLast Updated:December 24, 2020Recruiting

Phase 3 Study of ALK-001 in Geographic Atrophy

Condition(s):Geographic Atrophy; Age Related Macular Degeneration; AMD; Atrophy, GeographicLast Updated:July 8, 2020Recruiting

Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration

Condition(s):Age-Related Macular DegenerationLast Updated:October 22, 2020Recruiting

1 2 3 4 5 … »Last Page »

Trial Bulletin .com

Clinical Trials by Category

Clinical Trials Alphabetically

About

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.